Cherry Wine Strain: A Comprehensive Strain Guide

Origins and History of Cherry Wine

Cherry Wine emerged during the first wave of modern American hemp breeding that followed the 2014 Farm Bill pilot programs. As states ramped up compliant hemp cultivation, breeders sought chemotypes combining robust CBD yields with strong, marketable aromas. Cherry Wine quickly stood out for its pronounced cherry-and-pepper bouquet and its consistent high-CBD, low-THC expression, making it a favorite among early growers and boutique flower brands.

By 2016–2018, Cherry Wine had become a go-to cultivar for small and mid-scale hemp farms across Colorado, Oregon, and the Carolinas. The strain’s popularity was fueled by attractive flower quality—dense buds, resin-forward trichomes, and a terpene profile that cured well for retail. This was a period when the market rewarded cultivars that could pass compliance while still delivering a sensory experience closer to craft cannabis than commodity fiber hemp.

The name “Cherry Wine” references both flavor and mood: a sweet, fruit-led nose paired with a relaxing, glass-of-red-wine style calm without intoxication. The strain became associated with artisanal smokable hemp, a segment that grew rapidly in 2018–2020. During those seasons, several seed houses released stabilized lines and clone-only cuts marketed to maintain total THC under the legal threshold when harvested on time.

As regulatory testing rules matured—shifting from delta-9-only to total THC calculations—Cherry Wine remained in circulation thanks to conscientious phenohunts and earlier harvest windows. Many farms reported favorable CBD:THC ratios in the 20:1 to 28:1 range when using vetted seed lines or verified clones. With the ongoing refinement of breeding stock, Cherry Wine continues to be cultivated for flower, pre-rolls, and solventless extracts intended for CBD-dominant products.

This review focuses on the Cherry Wine strain specifically, acknowledging that different seed vendors and cuts can vary in compliance behavior, terpene distribution, and yield. Its history is emblematic of the broader evolution of hemp: a push for flavor, consistency, and regulatory reliability. Even now, Cherry Wine remains a benchmark for what a Type III CBD-dominant strain can deliver in both field and craft indoor settings.

Genetic Lineage and Breeding Background

Most breeders list Cherry Wine as a cross of The Wife and Charlotte’s Cherries. The Wife is a well-known high-CBD donor used to anchor CBD expression and minimize THC synthesis, often selected for strong CBDA production and calm, non-intoxicating effects. Charlotte’s Cherries contributes the fruit-forward aromatic intensity and further stabilizes the CBD-dominant chemotype.

While the exact parentage of Charlotte’s Cherries can vary by breeder description, it is generally agreed to descend from Charlotte’s Web-type genetics selected for CBD-rich expression. The cross aimed to meld a lively cherry-forward nose with agronomic resilience and low THC, essential for hemp compliance. Breeders then selected offspring with the most favorable CBD:THC ratios and terpene profiles to fix the Cherry Wine line.

In practice, “Cherry Wine” can denote a family of related lines—seed versions differ slightly among seed houses and seasons, and clone-only cuts may trace to specific standouts from original hunts. This diversity explains why some growers report 15–22% total cannabinoids, while others report slightly lower ceilings but tighter THC control. Over time, stabilized sub-lines and named cuts (often denoted by letters or numbers) have improved uniformity in field performance.

The breeding intent was to produce a Type III chemotype, where CBD dominates the cannabinoid profile and THC remains minimal. In stable expressions, CBD:THC ratios above 20:1 are typical when plants are harvested before late-season THC creep. These ratios support the cultivar’s reputation for delivering pronounced CBD effects without notable intoxication.

Cherry Wine’s breeding background also emphasizes resin density and terpene output, both valuable for solventless and hydrocarbon extraction. Many growers note that the cultivar presses well into rosin, with yields commonly in the 15–22% range from high-quality indoor flower. Such extraction-friendly traits have helped the strain maintain relevance even as the CBD market has matured.

Visual Characteristics and Bud Structure

Cherry Wine typically forms medium-sized, conical colas with calyx stacking that can range from medium-dense to dense depending on environment and nutrition. Mature flowers present a lively green base color with intermittent darker forest green patches, accented by vibrant orange to copper pistils. A silvery frost of trichomes blankets the buds, signaling strong resin production for a Type III cultivar.

Individual bracts are often plump, lending a rounded appearance to tops when fully swollen around weeks 7–8 of bloom indoors. Under optimal lighting, buds show a light-catching sheen that suggests good terpene retention in the heads. Some phenotypes exhibit faint anthocyanin expression in late flower, especially in cooler night temperatures, contributing to subtle purple hues.

Trimmed Cherry Wine buds commonly finish in the 0.6–1.6 gram range per nug for indoor craft markets, presenting uniformity that packages well. Field-grown, top colas are larger but can loosen slightly when late summer humidity rises, underscoring the importance of airflow. High-quality hand trims maintain a sugar-leaf edge that preserves trichome heads without over-stripping aromatics.

Close inspection reveals heads that are predominantly cloudy at peak harvest, with many growers targeting trichome maturity when 5–15% of heads have ambered just slightly. This timing helps balance CBD potency with THC compliance, as lingering too long can nudge THCA upward. The visual benchmark is a glossy, intact resin layer with minimal oxidation.

Overall, the cultivar’s bag appeal exceeds that of many early hemp lines, which often suffered from airy structure. Cherry Wine packs enough resin density to look at home next to craft cannabis flower, a key reason it became popular in smokable hemp channels. This visual appeal complements a robust nose that carries through from jar to grind.

Aroma and Bouquet

True to its name, Cherry Wine is dominated by sweet red fruit, akin to ripe cherry flesh and a hint of dark berry. Layered beneath is a peppery-spice ribbon reminiscent of cracked black pepper and clove, suggesting a caryophyllene influence. Earthy wood and light pine round out the base, keeping the profile from becoming candy-like.

Freshly ground flowers amplify the cherry top note, introducing nuances of cherry cola and a faint vanilla-like creaminess in some phenotypes. A subtle herbal lift—somewhere between thyme and tarragon—can appear, especially in well-cured indoor batches. The grind also releases more humulene-forward woody tones, balancing sweetness with depth.

On the stem rub late in veg, Many growers report a pre-flower aroma that presages the final bouquet: fruity but anchored by soft spice and wood. During the first two weeks of dry, terpenes evolve markedly, with the brighter cherry esters smoothing into a rounded, wine-like harmony by day 10–14. Keeping dry-room temperatures near 58–62°F and relative humidity around 60% helps retain the volatile top notes, which can otherwise flash off quickly.

Quantitatively, total terpene content for dialed-in indoor lots commonly lands around 1.8–3.2% by weight, with some exceptional cuts crossing 3.5%. Field-grown batches usually test slightly lower, often in the 0.8–1.8% range due to environmental stress, heat, and mechanical handling during harvest. Even within those ranges, Cherry Wine’s cherry-pepper identity remains distinct and easily identifiable in blind smell tests.

In cured flower, the nose projects well from the jar but blooms fully on the break. The bouquet is versatile in pre-rolls, maintaining character during combustion rather than washing out into generic hemp. This aromatic persistence is one reason the strain remains favored for consumer-facing flower SKUs.

Flavor and Mouthfeel

Cherry Wine’s flavor tracks closely with its aroma, delivering a front-of-palate cherry sweetness that is clean rather than syrupy. Early pulls often showcase a cherry-cola impression with a balsamic hint, followed by peppery tickle on the retrohale. Mid-palate, wood and pine add structure, creating a layered sip that evokes the “wine” moniker.

Combustion introduces gentle caramelized sugar notes as terpenes interact with heat, which can accentuate clove and black pepper. Vaporization at 350–380°F tends to preserve the cherry top note better, with users reporting a 20–30% perceived increase in fruitiness compared with smoking. At higher vapor temperatures (390–410°F), spicier caryophyllene and humulene facets become more pronounced.

Mouthfeel is medium-bodied with a soft, almost velvety texture at moderate humidity levels in the flower. Proper dry and cure yields smooth smoke; under-dried or speed-dried batches can exhibit astringency and mute the cherry. A water-curing or extended cure beyond four weeks can diminish high-note brightness, so many producers target 3–4 weeks in 58–62% RH jars.

Flavor persistence is above average for a CBD cultivar, often holding its character through the middle of a joint without collapsing into generic hay. In side-by-side tasting panels, Cherry Wine typically scores higher than basal hemp lines on sweetness and distinctiveness. This makes it an approachable choice for new consumers who want a pleasant, recognizable profile.

When pressed into rosin, the flavor concentrates into a cherry-spice resin that pairs well with fruit-forward edibles and cartridges. Post-press terpenes remain resilient if temperatures are kept below 200°F, with many processors noting that 180–190°F yields the best balance of flavor and flow. In short, Cherry Wine’s flavor is a strength that translates across consumption formats.

Cannabinoid Profile and Ratios

Cherry Wine is a Type III chemotype dominated by CBD, with total CBD commonly ranging from 9–18% by dry weight depending on phenotype and cultivation. Indoor, well-executed runs frequently test at 12–16% total CBD, with total cannabinoids reaching 14–22%. Outdoor or field-grown crops often report slightly lower totals due to environmental variability, typically 8–14% CBD.

THC expression remains low when harvest timing is controlled, usually 0.05–0.25% delta-9 THC and 0.05–0.25% THCA in compliant phenotypes. The regulatory metric in many U.S. jurisdictions is total THC, calculated as delta-9 THC + 0.877 × THCA. To remain under the 0.3% total THC threshold, growers frequently harvest when CBDA has plateaued but before late-season THCA accumulation.

CBD:THC ratios of 20:1 to 28:1 are common in well-bred Cherry Wine lines, though less-stable seed lots can show wider dispersion. In practical terms, a 15% CBD flower contains roughly 150 mg CBD per gram of dried material. A typical 0.5 g pre-roll would therefore deliver about 75 mg CBD, with inhalation bioavailability variably reported between 11% and 45% (often approximated around 30%).

Minor cannabinoids appear in trace to low-percentage amounts, often including CBC (0.1–0.6%), CBG (0.1–0.7%), and CBDV (0.05–0.3%). These minor constituents can subtly shape effects and flavor, and well-grown lots sometimes show a combined minor cannabinoid contribution of 0.5–1.5%. While not the headline, these compounds may enhance entourage effects alongside terpenes.

For extractors, Cherry Wine’s cannabinoid consistency is attractive for repeatable formulations. Winterized extracts from compliant flower commonly concentrate CBD to 60–75% in crude and 80–92% in distillate, depending on process efficiency. Such numbers allow reliable dosing in tinctures, vapes, and topicals tailored for non-intoxicating consumer segments.

Terpene Profile and Minor Aromatics

Cherry Wine’s terpene profile is typically led by myrcene, beta-caryophyllene, and humulene, with myrcene often testing in the 0.4–1.2% range by weight. Beta-caryophyllene frequently falls between 0.2–0.6%, contributing pepper-clove spice and potential CB2 receptor activity. Humulene usually lands between 0.1–0.4%, delivering woody, hops-like nuance that adds dryness to the finish.

Complementary terpenes often include alpha-pinene (0.05–0.25%) and beta-pinene (0.05–0.2%), lending a pine-resin brightness that lifts the cherry. Limonene can appear at 0.05–0.2%, accenting fruit and providing a crisp top note. Linalool is variable but commonly 0.03–0.12%, smoothing edges and contributing faint floral tones.

In some phenotypes, ocimene and farnesene trace above 0.05%, boosting perceived sweetness and giving a pear-like or floral halo. Bisabolol occasionally appears in the 0.02–0.08% range, imparting gentle honeyed notes and a soothing impression. These micro-components, while small in percentage, meaningfully affect the aromatic gestalt, particularly after cure.

Total terpene content for quality indoor batches generally measures 1.8–3.2% by weight, with field-grown lots averaging 0.8–1.8%. Careful post-harvest handling can retain up to 70–85% of pre-harvest terpene levels, while hot or fast drying can strip 25–55% of the most volatile fractions. This sensitivity underscores the importance of 60/60 drying (60°F, 60% RH) and gentle air exchange.

Beyond terpenes, esters and aldehydes likely contribute to the pronounced cherry character, though they are rarely quantified in standard cannabis lab panels. Consumers often report that the strain’s fruitiness seems to exceed what myrcene and limonene alone would suggest, hinting at minor volatiles playing above their percentage. This complexity is part of why Cherry Wine holds its name across cultivators and regions.

Experiential Effects and User Reports

Users commonly describe Cherry Wine as calming, clear-headed, and physically easing without intoxication. The onset via inhalation is fast—often within 2–5 minutes—with peak effect around 10–15 minutes and a duration of 60–120 minutes. Compared with THC-rich cannabis, psychotropic effects are minimal, with most users reporting no impairment.

Subjective effects center on muscle relaxation, decreased bodily tension, and a gentle lift in mood. Many describe a “glass-of-wine” unwind: a mellowing of stress reactivity and improved capacity to focus on light tasks or conversation. A small subset notes mild sedation at higher doses, particularly in the evening.

For daytime use, the strain’s clear baseline makes it compatible with work-from-home or creative planning sessions where calm is beneficial. At modest inhaled doses—one to three pulls—users often report reduction in somatic anxiety cues, such as tightness in the chest or jaw. The pepper-cherry flavor encourages slow, mindful pacing rather than overconsumption.

Tolerance and response vary with physiology and prior cannabinoid exposure. Individuals with no CBD experience may find that lower doses are sufficient, while regular users might prefer 25–75 mg inhaled CBD to notice pronounced changes. Because the cultivar’s THC is low, adverse reactions like racing heart or paranoia are uncommon.

Reports from consumer surveys and dispensary feedback indicate high satisfaction for relaxation and stress management use cases. In internal brand panels, Cherry Wine frequently scores in the top quartile for flavor enjoyment and repeat purchase intent. These qualitative data points align with the strain’s continued presence on menus despite shifting market trends.

Potential Medical and Wellness Applications

As a CBD-dominant cultivar, Cherry Wine aligns with research suggesting cannabidiol’s potential in anxiety modulation, inflammation reduction, and sleep support. Clinical literature indicates CBD may reduce anxiety in public speaking models and improve sleep measures in some cohorts, though results can be mixed and dose-dependent. Importantly